All Pfizer articles
-
NewsCommunity-based cohort study to track short- and long-term effects of multiple respiratory viruses
Scientists are initiating a critical two-year prospective epidemiologic study in the spring of 2024 to track acute respiratory infections across the United States.
-
NewsCovid-19 jab shows no serious side effects in young children
A review of more than 245,000 doses of mRNA COVID-19 vaccines given to young children - most of them aged 4 and younger - found no indications of serious side effects.
-
NewsVaccine for Lyme disease one step closer with promising six-month results
A vaccine for Lyme disease is one step closer after Pfizer Inc and Valneva SE reported positive results in their antibody persistence data six months after completing a three-dose or two-dose schdule in children and adults with vaccine candidate VLA15.
